Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WV › Summersville › NPI 1043778319
Lab

West Virginia Health Care Cooperative INC

West Virginia Health Care Cooperative INC was paid $19.20M by Medicaid between Jul 2019 and Dec 2024, across 235 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.

33Billing provider infoWEST VIRGINIA HEALTH CARE COOPERATIVE INC
SUMMERSVILLE, WV 26651
33aNPI1043778319assigned 03/06/2019
33bProvider typeClinical Medical Laboratory
28Total paid$19.20M
24GClaims376,531
24DCodes billed235
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in West Virginia

Rank by total paid#3 of 36
Median peer was paid$61K
This provider vs. median314×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201935,433$1.89M
202085,346$5.55M
202180,752$4.30M
202259,418$3.07M
202362,183$2.17M
2024incomplete53,399$2.23M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 17% 19,802 14,062 $3.28M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 9,639 6,861 $2.33M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 15,646 12,022 $2.01M
80053 Comprehensive metabolic panel 6.4% 28,478 21,079 $1.22M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 1,942 1,682 $594K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.9% 8,130 6,295 $552K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.8% 2,018 1,717 $533K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.7% 2,509 1,512 $520K
70450 Computed tomography, head or brain; without contrast material 2.4% 2,761 2,432 $470K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 33,431 24,119 $436K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.8% 8,893 6,823 $352K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.5% 3,053 2,295 $291K
223 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.4% 2,886 $269K
96375 Therapeutic injection; each additional sequential IV push 1.3% 7,660 $251K
87040 1.2% 4,090 $232K
71045 Radiologic examination, chest; single view 1.2% 8,461 $225K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 4,449 $222K
81001 1.1% 13,732 $203K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 497 $198K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,019 $189K
84484 <1% 7,704 $180K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 359 $177K
84443 Thyroid stimulating hormone (TSH) <1% 5,873 $175K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,145 $163K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 1,943 $151K
80048 Basic metabolic panel (calcium, ionized) <1% 6,125 $147K
36415 Collection of venous blood by venipuncture <1% 35,847 $145K
83690 <1% 5,882 $126K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,286 $122K
71046 Radiologic examination, chest; 2 views <1% 3,001 $121K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 835 $111K
80061 Lipid panel <1% 3,651 $111K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,597 $104K
83880 <1% 2,083 $104K
96361 Intravenous infusion, hydration; each additional hour <1% 3,599 $102K
G0378 Hospital observation service, per hour <1% 1,070 $97K
93017 <1% 428 $87K
84703 <1% 1,712 $87K
96376 <1% 2,200 $86K
72125 Computed tomography, cervical spine; without contrast material <1% 375 $81K
84439 <1% 2,003 $78K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,039 $77K
77067 Screening mammography, bilateral, including computer-aided detection <1% 877 $77K
83735 <1% 5,166 $76K
76770 <1% 532 $67K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,143 $60K
85379 <1% 1,236 $55K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,688 $54K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 504 $54K
71250 <1% 238 $50K
72110 <1% 574 $48K
76830 Ultrasound, transvaginal <1% 395 $47K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 568 $46K
83036 Hemoglobin; glycosylated (A1C) <1% 2,351 $46K
J2704 Injection, propofol, 10 mg <1% 3,472 $43K
85610 <1% 3,835 $41K
83605 <1% 5,747 $40K
73562 <1% 923 $39K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 175 $38K
86140 <1% 1,397 $36K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 80 $36K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,426 $36K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 257 $36K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 390 $35K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 83 $34K
73030 <1% 1,002 $33K
94664 <1% 515 $32K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 800 $32K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 309 $31K
73630 <1% 844 $29K
82607 <1% 701 $28K
82803 <1% 1,184 $28K
85027 <1% 2,799 $25K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 640 $24K
93971 <1% 337 $23K
73610 <1% 669 $23K
84702 <1% 401 $22K
76536 <1% 221 $22K
85730 <1% 1,977 $22K
82550 <1% 1,781 $21K
74018 <1% 479 $20K
73130 <1% 452 $19K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 306 $18K
74019 <1% 197 $18K
73110 <1% 434 $17K
99214 Doctor's office visit, returning patient (more involved) <1% 2,082 $17K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,217 $15K
82570 <1% 643 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,520 $14K
J2785 Injection, regadenoson, 0.1 mg <1% 101 $14K
82553 <1% 266 $14K
72050 <1% 174 $13K
80179 <1% 187 $13K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,551 $13K
85651 <1% 789 $13K
80143 <1% 188 $13K
86850 <1% 587 $12K
96367 <1% 348 $12K
20610 <1% 240 $12K
76642 <1% 120 $11K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 25 $11K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 186 $11K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 390 $11K
84466 <1% 304 $10K
86901 <1% 626 $9K
86900 <1% 626 $9K
83540 <1% 669 $9K
36600 <1% 293 $9K
87147 <1% 399 $9K
87081 <1% 324 $8K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 39 $8K
J7120 Ringers lactate infusion, up to 1000 cc <1% 118 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,188 $8K
70486 <1% 28 $8K
82728 <1% 262 $8K
J7030 Infusion, normal saline solution , 1000 cc <1% 576 $7K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 3,246 $7K
74022 <1% 132 $7K
72131 <1% 31 $7K
73564 <1% 186 $7K
87070 <1% 229 $7K
99213 Doctor's office visit, returning patient (routine) <1% 963 $7K
72072 <1% 109 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,476 $7K
81025 <1% 787 $6K
72100 <1% 126 $6K
73502 <1% 168 $6K
99204 Doctor's office visit, new patient (more involved) <1% 516 $6K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,125 $6K
87807 <1% 79 $6K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 560 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,148 $6K
80074 <1% 26 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 366 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 558 $5K
87205 <1% 397 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 95 $5K
82150 <1% 190 $5K
J1650 Injection, enoxaparin sodium, 10 mg <1% 803 $5K
90715 <1% 295 $5K
88304 <1% 135 $5K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 147 $4K
87186 <1% 165 $4K
80050 General health panel <1% 57 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 68 $4K
84075 <1% 196 $4K
J2270 Injection, morphine sulfate, up to 10 mg <1% 859 $4K
73590 <1% 98 $4K
85378 <1% 53 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 261 $3K
84100 <1% 271 $3K
73090 <1% 88 $3K
J3490 Unclassified drugs <1% 2,473 $3K
82248 <1% 220 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 64 $3K
51702 <1% 78 $3K
93880 <1% 13 $3K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 54 $2K
82140 <1% 67 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 326 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 55 $2K
82043 <1% 433 $2K
77065 Tomosynthesis, mammo <1% 28 $2K
88342 <1% 24 $2K
85007 <1% 156 $2K
77063 Screening digital breast tomosynthesis, bilateral <1% 47 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 18 $2K
76641 <1% 18 $2K
94060 <1% 15 $2K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 17 $2K
99203 Doctor's office visit, new patient (routine) <1% 170 $1K
86038 <1% 48 $1K
J3370 Injection, vancomycin hcl, 500 mg <1% 114 $1K
86618 <1% 61 $1K
94761 <1% 105 $1K
82247 <1% 87 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 318 $1K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 279 $1K
73080 <1% 34 $1K
82565 <1% 72 $1K
71100 <1% 15 $1K
J1815 Injection, insulin, per 5 units <1% 108 $996.89
82040 <1% 63 $963.88
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 146 $955.58
84550 <1% 65 $949.05
86803 <1% 31 $942.91
84520 <1% 44 $921.81
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 177 $773.88
80051 <1% 20 $755.39
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 112 $738.43
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 199 $663.34
J2060 Injection, lorazepam, 2 mg <1% 171 $615.17
82310 <1% 20 $609.62
94760 <1% 241 $586.11
87210 <1% 13 $567.63
84450 <1% 18 $519.67
84460 <1% 18 $519.67
85652 <1% 101 $379.23
J2780 Injection, ranitidine hydrochloride, 25 mg <1% 23 $358.27
E0110 Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips <1% 27 $347.02
82746 <1% 14 $296.30
82977 <1% 18 $283.46
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 107 $268.77
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 16 $218.29
93018 <1% 27 $211.56
93016 <1% 27 $178.87
J1940 Injection, furosemide, up to 20 mg <1% 101 $164.96
90656 <1% 29 $155.19
J1956 Injection, levofloxacin, 250 mg <1% 41 $152.53
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 17 $139.93
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 89 $121.41
J0780 Injection, prochlorperazine, up to 10 mg <1% 71 $120.53
J1170 Injection, hydromorphone, up to 4 mg <1% 16 $117.57
51798 <1% 16 $115.51
A4649 Surgical supply; miscellaneous <1% 24 $111.18
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 12 $97.34
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 34 $67.47
99222 Initial hospital care, per day, moderate complexity <1% 16 $42.31
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 14 $34.69
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 73 $24.64
J0456 Injection, azithromycin, 500 mg <1% 33 $14.21
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit <1% 63 $14.06
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 33 $11.17
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 12 $0.69
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 23 $0.03
G9903 Patient screened for tobacco use and identified as a tobacco non-user 0% 112 $0.00
1036F 0% 112 $0.00
Q0240 Injection, casirivimab and imdevimab, 600 mg 0% 19 $0.00
1123F 0% 18 $0.00
G9902 Patient screened for tobacco use and identified as a tobacco user 0% 15 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 85 $0.00
4004F 0% 15 $0.00
90653 0% 23 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 152 $0.00
1124F 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWLING, KAREN (PRESIDENT/CEO)
Same official

Other billing entities under BOWLING, KAREN

Full network →
ProviderLocationPaid
City of JacksonvilleJacksonville, FL$17.10M
West Virginia Health Care Cooperative INCSummersville, WV$3.09M
West Virginia Health Care Cooperative INCSummersville, WV$1.61M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.